Search results

At ANSTO we understand that diverse teams produce better outcomes – and we value the merit that a diverse perspective can bring to the quality and outcomes of our work, and the way we get the job done.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

The mechanical, electrical, chemical, optical and thermal properties of glass, as determined by its chemical composition and atomic structure, make it a highly useful material with a myriad of applications.

There have been significant developments in small modular reactor technologies in 2022. The International Atomic Energy Agency expects small modular reactors (SMRs) to make an important contribution to achieving global climate goals and energy supply security. But with more than 70 SMR designs under development in 18 countries – including innovative reactors that are yet to be licensed and novel methods of modular manufacturing that are new to the nuclear industry – widely deploying SMRs in time remains a tall task.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Quantum theory explains the strange and unpredictable behaviour of subatomic particles and the smallest amounts of energy.

The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.

ANSTO has contributed to international research on quasicrystals that opens the door to tailored magnetic materials.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

The process by which plastic degrades in the ocean facilitates its entry into the natural carbon cycle efficiently as carbon dioxide.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.